ONCOTHERAPY SCIENCE INC financial statements, including revenue, expenses, profit, and loss
The total revenue of 4564 for the last quarter is 109.55 M JPY, and it's 47.41% lower compared to the previous quarter. The net income of Q3 23 is -276.67 M JPY.